TriSalus Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TLSI and other ETFs, options, and stocks.

About TLSI

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO. 

CEO
Mary T. Szela
CEOMary T. Szela
Employees
110
Employees110
Headquarters
Westminster, Colorado
HeadquartersWestminster, Colorado
Founded
2020
Founded2020
Employees
110
Employees110

TLSI Key Statistics

Market cap
186.37M
Market cap186.37M
Price-Earnings ratio
-4.24
Price-Earnings ratio-4.24
Dividend yield
Dividend yield
Average volume
33.81K
Average volume33.81K
High today
$5.78
High today$5.78
Low today
$5.53
Low today$5.53
Open price
$5.66
Open price$5.66
Volume
19.51K
Volume19.51K
52 Week high
$10.24
52 Week high$10.24
52 Week low
$3.50
52 Week low$3.50

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.